Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.48% | 18.22% | 27.47% | 30.44% | 50.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.48% | 18.22% | 27.47% | 30.44% | 50.64% |
| Cost of Revenue | 77.34% | 74.02% | 36.46% | 39.64% | 418.29% |
| Gross Profit | 1.55% | -0.36% | 23.31% | 26.19% | 21.86% |
| SG&A Expenses | 13.55% | 11.42% | 16.89% | 19.62% | -23.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -7.41% | -9.14% | 3.43% | 5.84% | 170.75% |
| Total Operating Expenses | 17.52% | 15.32% | 15.86% | 18.57% | 23.49% |
| Operating Income | -5.73% | -3.75% | 4.91% | 2.70% | 28.13% |
| Income Before Tax | -12.57% | -10.45% | 4.11% | 1.88% | 69.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.57% | -10.45% | 4.11% | 1.88% | 64.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.57% | -10.45% | 4.11% | 1.88% | 64.06% |
| EBIT | -5.73% | -3.75% | 4.91% | 2.70% | 28.13% |
| EBITDA | -173.99% | -168.91% | 4.68% | 2.45% | 83.96% |
| EPS Basic | 8.33% | 10.42% | 19.79% | 18.56% | 72.57% |
| Normalized Basic EPS | 6.67% | 10.00% | 20.00% | 18.33% | 45.45% |
| EPS Diluted | 8.33% | 10.42% | 19.79% | 18.56% | 72.57% |
| Normalized Diluted EPS | 6.67% | 10.00% | 20.00% | 18.33% | 45.45% |
| Average Basic Shares Outstanding | 21.84% | 21.84% | 20.38% | 20.38% | 31.00% |
| Average Diluted Shares Outstanding | 21.84% | 21.84% | 20.38% | 20.38% | 31.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |